1.77 USD
▼-1.02-36.56%
盘后 2.05 +15.82%
2026-11-20
市值
$1.67M
市盈率
—
EPS
-1.43
股息率
—
52 周区间
1.71 – 95.04
成交量
38.91K
Beta
2.32
目标价
445.50
52W 低 1.7152W 高 95.04
价格走势
公司简介
Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The company’s lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cells to create CAR-NK cells outfitted with gene circuit technologies in various oncology indications with unmet need. It offers SENTI-202, a logic gated off-the-shelf CAR-NK cell therapy for the treatment of blood cancers and relapsed...